Detalles de la búsqueda
1.
Dostarlimab, an anti-programmed death-1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration-QT analysis.
Br J Clin Pharmacol;
89(7): 2272-2282, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36823349
2.
JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer.
Cancer;
128(1): 65-74, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478166
3.
Population pharmacokinetics and exposure-response of anti-programmed cell death protein-1 monoclonal antibody dostarlimab in advanced solid tumours.
Br J Clin Pharmacol;
88(9): 4142-4154, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35357027
4.
A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas.
Br J Cancer;
121(2): 131-138, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217479
5.
Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects.
Support Care Cancer;
27(3): 819-827, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30084103
6.
Fornix Microstructure and Memory Performance Is Associated with Altered Neural Connectivity during Episodic Recognition.
J Int Neuropsychol Soc;
22(2): 191-204, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26888616
7.
Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma.
Gynecol Oncol;
137(1): 28-33, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25666606
8.
Comparative analysis of PD-1 target engagement of dostarlimab and pembrolizumab in advanced solid tumors using ex vivo IL-2 stimulation data.
CPT Pharmacometrics Syst Pharmacol;
12(1): 87-94, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36317409
9.
Transdiagnostic clustering of self-schema from self-referential judgements identifies subtypes of healthy personality and depression.
Front Neuroinform;
17: 1244347, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38274390
10.
Testing the myth of the encoding-retrieval match.
Mem Cognit;
40(1): 28-39, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21830162
11.
Positive mental health in psychotherapy: a qualitative study from psychotherapists' perspectives.
BMC Psychol;
10(1): 111, 2022 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35488353
12.
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial.
Cancer Chemother Pharmacol;
89(1): 93-103, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750637
13.
IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin-paclitaxel, with or without bevacizumab in patients with advanced cancer.
J Immunother Cancer;
10(3)2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35332062
14.
Investigation of the pyrazinones as PDE5 inhibitors: evaluation of regioisomeric projections into the solvent region.
Bioorg Med Chem Lett;
21(21): 6348-52, 2011 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21955943
15.
Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models.
MAbs;
13(1): 1954136, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34313545
16.
A Randomised Controlled Trial of Clinician-Guided Internet-Based Cognitive Behavioural Therapy for Depressed Patients in Singapore.
Front Psychol;
12: 668384, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34393903
17.
"We Are All Trying to Find a Way to Help Ourselves": A Look at Self-Help Strategies Among Psychotherapy Clients.
Front Psychol;
12: 621085, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34690850
18.
An Integrated Analysis of Dostarlimab Immunogenicity.
AAPS J;
23(5): 96, 2021 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324079
19.
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.
Clin Cancer Res;
14(16): 5260-9, 2008 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18698046
20.
Pharmacokinetics, Safety, and Tolerability of Rolapitant Administered Intravenously Following Single Ascending and Multiple Ascending Doses in Healthy Subjects.
Clin Pharmacol Drug Dev;
8(2): 160-171, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29905976